Avapro

Avapro

Price from 48.00 $
Product dosage: 150mg
Package (num)Per pillPriceBuy
30$1.62$48.48 (0%)πŸ›’ Add to cart
60$1.13$96.96 $67.67 (30%)πŸ›’ Add to cart
90$0.97$145.43 $86.86 (40%)πŸ›’ Add to cart
120$0.88$193.91 $106.05 (45%)πŸ›’ Add to cart
180$0.81$290.87 $145.43 (50%)πŸ›’ Add to cart
270$0.76$436.30 $205.02 (53%)πŸ›’ Add to cart
360
$0.73 Best per pill
$581.74 $261.58 (55%)πŸ›’ Add to cart
Product dosage: 300mg
Package (num)Per pillPriceBuy
30$1.95$58.58 (0%)πŸ›’ Add to cart
60$1.38$117.16 $82.82 (29%)πŸ›’ Add to cart
90$1.20$175.73 $108.07 (39%)πŸ›’ Add to cart
120$1.09$234.31 $131.29 (44%)πŸ›’ Add to cart
180$1.00$351.47 $180.78 (49%)πŸ›’ Add to cart
270
$0.94 Best per pill
$527.20 $253.50 (52%)πŸ›’ Add to cart
Synonyms

Similar products

Avapro: Effective Blood Pressure Control for Cardiovascular Health

Avapro (irbesartan) is an angiotensin II receptor blocker (ARB) prescribed for the management of hypertension, offering reliable and sustained blood pressure reduction. It works by blocking the action of certain natural substances that tighten blood vessels, allowing blood to flow more smoothly. This medication is also indicated to protect kidney function in patients with type 2 diabetes and hypertension, reducing the risk of further renal impairment. By maintaining optimal blood pressure levels, Avapro helps lower the overall risk of strokes, heart attacks, and kidney problems. Its once-daily dosing supports patient adherence and consistent therapeutic outcomes.

Features

  • Active ingredient: Irbesartan
  • Drug class: Angiotensin II receptor blocker (ARB)
  • Available in tablet form: 75 mg, 150 mg, 300 mg strengths
  • Administration: Oral, once daily
  • Prescription-only medication
  • Long-acting formulation for 24-hour coverage

Benefits

  • Effectively lowers high blood pressure, reducing strain on the heart and arteries.
  • Helps decrease the risk of cardiovascular events such as stroke and heart attack.
  • Provides renal protection in hypertensive patients with type 2 diabetes by slowing kidney damage.
  • Supports consistent blood pressure control with convenient once-daily dosing.
  • Generally well-tolerated with a lower incidence of certain side effects like cough compared to ACE inhibitors.
  • Contributes to overall long-term cardiovascular and renal health management.

Common use

Avapro is primarily used for the treatment of hypertension in adults, either as monotherapy or in combination with other antihypertensive agents. It is also approved for the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes, as it has been shown to slow the progression of renal disease. Healthcare providers may prescribe it off-label in certain cases where angiotensin II receptor blockade is indicated, though such use should be carefully evaluated based on individual patient profiles and clinical evidence.

Dosage and direction

The recommended initial dose of Avapro for hypertension is 150 mg taken orally once daily. Dosage may be increased to 300 mg once daily if blood pressure remains uncontrolled. For volume-depleted patients, consider starting with 75 mg. In the management of diabetic nephropathy, the recommended maintenance dose is 300 mg once daily. Avapro may be taken with or without food. It is important to take this medication at the same time each day to maintain steady blood levels. Do not crush or chew the tablets; swallow them whole with a glass of water.

Precautions

Before taking Avapro, inform your healthcare provider if you have a history of kidney disease, liver impairment, heart conditions, or dehydration. Avoid use during pregnancy, as it can cause injury or death to the developing fetus. Use with caution in patients with renal artery stenosis, as it may worsen kidney function. Monitor serum potassium levels periodically, especially in patients with renal insufficiency or diabetes. Elderly patients may require dose adjustment based on renal function. Avoid alcohol consumption, as it may further lower blood pressure and increase dizziness.

Contraindications

Avapro is contraindicated in patients with known hypersensitivity to irbesartan or any component of the formulation. Do not use in combination with aliskiren in patients with diabetes. It is contraindicated during pregnancy due to the risk of fetal harm. Avoid use in patients with severe hepatic impairment or biliary cirrhosis. Concomitant use with ACE inhibitors is generally not recommended due to increased risks of hyperkalemia, hypotension, and renal impairment.

Possible side effect

Common side effects may include dizziness, lightheadedness, or upset stomach. Less frequently, patients may experience fatigue, muscle pain, or diarrhea. Serious side effects, though rare, can include symptoms of high potassium levels (such as muscle weakness, slow heart rate), signs of kidney problems (change in amount of urine), or severe allergic reactions (rash, itching, swelling). Immediately report any symptoms of infection, such as fever or sore throat, as these could indicate rare blood disorders. Most side effects are mild and often diminish with continued use.

Drug interaction

Avapro may interact with other medications that increase potassium levels, such as potassium supplements, salt substitutes, or certain diuretics. Concurrent use with NSAIDs (e.g., ibuprofen) may reduce the antihypertensive effect and impair renal function. Use caution with lithium, as irbesartan can increase lithium levels. Combining with other antihypertensive agents may potentiate blood pressure-lowering effects. Avoid concomitant use with ACE inhibitors or aliskiren in specific patient populations due to increased risk of adverse events.

Missed dose

If you miss a dose of Avapro, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up. Consistent adherence is important for maintaining blood pressure control, so consider setting a daily reminder to help avoid missed doses.

Overdose

Symptoms of Avapro overdose may include severe dizziness, fainting, or unusually fast or slow heartbeat. In cases of significant hypotension, supportive measures such as intravenous fluids or vasoconstrictors may be necessary. There is no specific antidote for irbesartan overdose. Management should focus on symptomatic and supportive care, including monitoring of vital signs and electrolyte levels. If overdose is suspected, seek immediate medical attention or contact a poison control center.

Storage

Store Avapro tablets at room temperature (20–25Β°C or 68–77Β°F), in a tightly closed container, and away from light, moisture, and heat. Keep out of reach of children and pets. Do not store in the bathroom or other damp areas. Properly discard any expired or unused medication as advised by your pharmacist or local disposal guidelines to prevent accidental ingestion or environmental contamination.

Disclaimer

This information is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Do not disregard professional medical advice or delay in seeking it because of something you have read here. Individual patient responses to Avapro may vary, and only a healthcare professional can determine the appropriate therapy based on specific health circumstances.

Reviews

Clinical studies and patient reports generally reflect positive experiences with Avapro, noting effective blood pressure control and good tolerability. Some users mention minimal side effects compared to other antihypertensive agents. However, individual responses can vary, and a few reports highlight instances of dizziness or elevated potassium levels. Overall, it is regarded as a reliable option within its class for long-term hypertension management, particularly in patients with concomitant type 2 diabetes. Always consult with a healthcare provider for personalized assessments.